S'abonner

Myocardial perfusion, function, and dyssynchrony in patients with heart failure: Baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial - 13/08/11

Doi : 10.1016/j.ahj.2009.07.009 
Allen E. Atchley, MD a, Dalane W. Kitzman, MD b, David J. Whellan, MD c, Ami E. Iskandrian, MD d, Stephen J. Ellis, PhD a, Robert A. Pagnanelli, NCT a, Andrew Kao, MD e, Khaled Abdul-Nour, MD f, Christopher M. O'Connor, MD a, Greg Ewald, MD g, William E. Kraus, MD a, Salvador Borges-Neto, MD a,

for the HF-ACTION Investigatorsh

a Duke University Medical Center, Durham, NC 
b Wake Forest University School of Medicine, Winston-Salem, NC 
c Jefferson Medical College, Philadelphia, PA 
d University of Alabama at Birmingham, Birmingham, AL 
e Mid-America Heart Institute, Kansas City, MO 
f Henry Ford Hospital, Detroit, MI 
g Washington University, St. Louis, MO 
h A complete list of the HF-ACTION investigators is available as an appendix in the introduction of this supplement. 

Reprint requests: Salvador Borges-Neto, MD, Department of Medicine and Radiology, Duke University Medical Center, Durham, NC 27710.

Résumé

Background

There are currently limited data on the relationships between resting perfusion abnormalities, left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) functional class, and exercise capacity as defined by peak V̇o2 and 6-minute walk test in patients with heart failure (HF) and reduced LVEF. Furthermore, the association between resting perfusion abnormalities and left ventricular dyssynchrony is currently unknown. This article addresses the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) gated SPECT imaging (gSPECT) substudy baseline results.

Methods

HF-ACTION was a multicenter, randomized controlled trial of aerobic exercise training versus usual care in 2,331 stable patients with LVEF of ≤35% and NYHA class II to IV HF symptoms treated with optimal medical therapy. Subjects enrolled in the HF-ACTION substudy underwent resting Tc-99m tetrofosmin gSPECT at baseline (n = 240). Images were evaluated for extent and severity of perfusion abnormalities using a 17-segment and a 5-degree gradation severity score (summed rest score [SRS]). Left ventricular function and dyssynchrony were assessed using validated available commercial software.

Results

The average age of patients enrolled was 59, 69% were male, 63% were white, and 33% were African American. Of the 240 participants, 129 (54%) were ischemic and 111 (46%) were nonischemic in etiology. The median LVEF by gSPECT for the entire cohort was 26%. Among the nuclear variables, there was a modest correlation between LVEF and SRS (r = −0.31, P < .0001) and there were stronger correlations between phase SD and SRS (r = 0.66, P < .0001) as well as phase SD and LVEF (r = −0.50, P < .0001). Patients with NYHA class III symptoms had more severe and significant degrees of dyssynchrony (median phase SD 54°) than those with NYHA class II symptoms (median phase SD 39°, P = .001). Patients with an ischemic etiology had a higher SRS (P < .0001) and significantly more dyssynchrony (P < .0001) than those who were nonischemic. However, there was no difference in LVEF or objective measures of exercise capacity between these groups. With respect to peak V̇o2, there was a weak correlation with LVEF (r = 0.18, P = .006) and no correlation with SRS (r = −0.04, P = 0.59) or with dyssynchrony (r = −0.13, P = .09). A weak but statistically significant correlation between SRS and 6-minute walk was observed (r = −0.15, P = .047).

Conclusions

Gated SPECT imaging can provide important information in patients with HF due to severe LV dysfunction including quantitative measures of global systolic function, perfusion, and dyssynchrony. These measurements are modestly but significantly related to symptom severity and objective measures of exercise capacity.

Le texte complet de cet article est disponible en PDF.

Plan


 ClinicalTrials.gov Identifier: NCT00047437.
 Funding was received from National Institutes of Health (grants 5U01HL063747, 5U01HL068973, 5U01HL066501, 5U01HL066482, 5U01HL064250, 5U01HL066494, 5U01HL064257, 5U01HL066497, 5U01HL068980, 5U01HL064265, 5U01HL066491, 5U01HL064264, 5U01HL066461, R37AG18915, and P60AG10484).


© 2009  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 158 - N° 4S

P. S53-S63 - octobre 2009 Retour au numéro
Article précédent Article précédent
  • Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study
  • Julius M. Gardin, Eric S. Leifer, Jerome L. Fleg, David Whellan, Peter Kokkinos, Marie-Helene LeBlanc, Eugene Wolfel, Dalane W. Kitzman, for the HF-ACTION Investigators
| Article suivant Article suivant
  • Outcomes, health policy, and managed care: Relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure
  • Kathryn E. Flynn, Li Lin, Stephen J. Ellis, Stuart D. Russell, John A. Spertus, David J. Whellan, Ileana L. Piña, Lawrence J. Fine, Kevin A. Schulman, Kevin P. Weinfurt, for the HF-ACTION Investigators j

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.